A hybrid strategy with bioresorbable vascular scaffolds and drug eluting stents for treating complex coronary lesions

In conclusion, the use of a hybrid BVS/DES strategy was feasible and associated with acceptable outcomes at 1-year, considering the length and complexity of lesions treated. Further, larger studies with longer follow-up are needed to confirm our findings.